Switch to rosuvastatin leads to greater LDL-C reduction

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1436, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduction of Serum LDL-C Levels: A Relationship to Clinical Benefits

By LaRosa J.C.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 271-281

Adis International

Access to resources Recommend Favorite

Rosuvastatin: A Review of its Use in the Prevention of Cardiovascular Disease in Apparently Healthy Women or Men with Normal LDL-C Levels and Elevated hsCRP Levels

By Carter Natalie J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 6, 2010-12 ,pp. : 383-400

Adis International

Access to resources Recommend Favorite

Intensive atorvastatin reduces CRP, LDL-C in acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Rosuvastatin leads the way in metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Rosuvastatin effectively reduces LDL-cholesterol in HFH

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite